By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...